Select Page

Australia & New Zealand

In Australia we market pharmaceutical products including a portfolio of branded dermatology products and a range of oral and specialty generics. We also manufacture poppy-derived opiate raw materials that are primarily used in the manufacture of analgesics. All products are manufactured to meet the stringent standards of the Australian Therapeutic Goods Administration.

Globally, our vertically integrated operations including manufacturing of Active Pharmaceutical Ingredients (APIs) and Finished Dosage formulations, together with robust R&D capabilities, enable us to maintain strict control over the quality and cost of our marketed products.

We provide high-quality, affordable medicines trusted by healthcare professionals and patients in over 100 countries of the world. Our global presence is supported by 43 manufacturing facilities across 6 continents. We have a multi-cultural workforce comprising more than 41,000 employees in over 50 nationalities.

Contact

Sun Pharma ANZ Pty Ltd,
Suite 2.02,
Level 2,
12 Waterloo Road,
Macquarie Park NSW 2113,
Australia.

(02) 9887 2600
Fax No.: +61 (0)2 8008 1639
[email protected]
Toll Free: 1800 726 229

ADVERSE EVENT REPORTING
Australian Pharmacovigilance Department
Sun Pharma ANZ,
Suite 2.02, Level 2,
12 Waterloo Road,
Macquarie Park NSW 2113,
Australia.

Tel. No.: 1800 726 229
Fax No.: (02) 8008 1639
[email protected]

Global Pharmacovigilance Department
Sun Pharmaceutical Industries Ltd.
SUN HOUSE,
CTS No. 201 B/1,
Western Express Highway,
Goregaon (E),
Mumbai 400063
INDIA

Tel. No.: (+91 22) 4324 4324
Please click here to fill an online adverse event reporting form

Please contact Sun Pharma ANZ Med Info for access by either email: [email protected] or Tel. No.: 1800 726 229

Top